Home - Products - Others - Other Targets - Isovitexin-2-O-rhamnoside (2-O-alpha-L-Rhamnopyranosyl-isovitexin)

Isovitexin-2-O-rhamnoside (2-O-alpha-L-Rhamnopyranosyl-isovitexin)

CAS No. 72036-50-1

Isovitexin-2-O-rhamnoside (2-O-alpha-L-Rhamnopyranosyl-isovitexin)( —— )

Catalog No. M32221 CAS No. 72036-50-1

Isovitexin-2''-O-rhamnoside has a role as an antifeedant and a plant metabolite.Antioxidant activities.Anti-hepatotoxic activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 141 In Stock
10MG 241 In Stock
25MG 508 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isovitexin-2-O-rhamnoside (2-O-alpha-L-Rhamnopyranosyl-isovitexin)
  • Note
    Research use only, not for human use.
  • Brief Description
    Isovitexin-2''-O-rhamnoside has a role as an antifeedant and a plant metabolite.Antioxidant activities.Anti-hepatotoxic activities.
  • Description
    Isovitexin-2''-O-rhamnoside has a role as an antifeedant and a plant metabolite.Antioxidant activities.Anti-hepatotoxic activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    72036-50-1
  • Formula Weight
    578.5
  • Molecular Formula
    C27H30O14
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J Agric Food Chem . 2013 Nov 6;61(44):10507-15.
molnova catalog
related products
  • Endokinin A/B

    Endokinin A/B

  • AC1NS4RE

    SU5614 is a potent and selective FLT3 inhibitor. SU5614 has inhibitory activity for FLT3 and selectively induces growth arrest, apoptosis, and cell cycle arrest in Ba/F3 and AML cell lines expressing a constitutively activated FLT3.

  • VPC-13163

    VPC-13163 has strong anti-proliferative activity against LNCaP and Enzalutamide-resistant prostate cancer cell lines (MR49F) whereas it did not affect the growth of AR independent PC3 cell line.